These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 8255458)

  • 1. [18F]FDG PET in fatal familial insomnia: the functional effects of thalamic lesions.
    Perani D; Cortelli P; Lucignani G; Montagna P; Tinuper P; Gallassi R; Gambetti P; Lenzi GL; Lugaresi E; Fazio F
    Neurology; 1993 Dec; 43(12):2565-9. PubMed ID: 8255458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebral metabolism in fatal familial insomnia: relation to duration, neuropathology, and distribution of protease-resistant prion protein.
    Cortelli P; Perani D; Parchi P; Grassi F; Montagna P; De Martin M; Castellani R; Tinuper P; Gambetti P; Lugaresi E; Fazio F
    Neurology; 1997 Jul; 49(1):126-33. PubMed ID: 9222180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Errors introduced by tissue heterogeneity in estimation of local cerebral glucose utilization with current kinetic models of the [18F]fluorodeoxyglucose method.
    Schmidt K; Lucignani G; Moresco RM; Rizzo G; Gilardi MC; Messa C; Colombo F; Fazio F; Sokoloff L
    J Cereb Blood Flow Metab; 1992 Sep; 12(5):823-34. PubMed ID: 1506447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebral metabolic rate for glucose during the first six months of life: an FDG positron emission tomography study.
    Kinnala A; Suhonen-Polvi H; Aärimaa T; Kero P; Korvenranta H; Ruotsalainen U; Bergman J; Haaparanta M; Solin O; Nuutila P; Wegelius U
    Arch Dis Child Fetal Neonatal Ed; 1996 May; 74(3):F153-7. PubMed ID: 8777676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Regional cerebral glucose metabolism associated with ataxic gait--an FDG-PET activation study in patients with olivopontocerebellar atrophy].
    Mishina M; Senda M; Ohyama M; Ishii K; Kitamura S; Terashi A
    Rinsho Shinkeigaku; 1995 Nov; 35(11):1199-204. PubMed ID: 8720328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pre-symptomatic diagnosis in fatal familial insomnia: serial neurophysiological and 18FDG-PET studies.
    Cortelli P; Perani D; Montagna P; Gallassi R; Tinuper P; Provini F; Avoni P; Ferrillo F; Anchisi D; Moresco RM; Fazio F; Parchi P; Baruzzi A; Lugaresi E; Gambetti P
    Brain; 2006 Mar; 129(Pt 3):668-75. PubMed ID: 16399807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [18F-fluorodeoxyglucose positron emission tomography in Parkinson's disease].
    Arahata Y; Kato T; Tadokoro M; Sobue G
    Nihon Rinsho; 1997 Jan; 55(1):222-6. PubMed ID: 9014454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Basal ganglia and thalamo-cortical hypermetabolism in patients with spasmodic torticollis.
    Galardi G; Perani D; Grassi F; Bressi S; Amadio S; Antoni M; Comi GC; Canal N; Fazio F
    Acta Neurol Scand; 1996 Sep; 94(3):172-6. PubMed ID: 8899050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serial positron emission tomographic findings in an atypical presentation of fatal familial insomnia.
    Bär KJ; Häger F; Nenadic I; Opfermann T; Brodhun M; Tauber RF; Patt S; Schulz-Schaeffer W; Gottschild D; Sauer H
    Arch Neurol; 2002 Nov; 59(11):1815-8. PubMed ID: 12433271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lowered cerebral glucose utilization in amyotrophic lateral sclerosis.
    Dalakas MC; Hatazawa J; Brooks RA; Di Chiro G
    Ann Neurol; 1987 Nov; 22(5):580-6. PubMed ID: 3501273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic patterns in prion diseases: an FDG PET voxel-based analysis.
    Prieto E; Domínguez-Prado I; Riverol M; Ortega-Cubero S; Ribelles MJ; Luquin MR; de Castro P; Arbizu J
    Eur J Nucl Med Mol Imaging; 2015 Sep; 42(10):1522-9. PubMed ID: 26041084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic changes of subcortical structures in intractable focal epilepsy.
    Benedek K; Juhász C; Muzik O; Chugani DC; Chugani HT
    Epilepsia; 2004 Sep; 45(9):1100-5. PubMed ID: 15329075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crossed cerebellar and uncrossed basal ganglia and thalamic diaschisis in Alzheimer's disease.
    Akiyama H; Harrop R; McGeer PL; Peppard R; McGeer EG
    Neurology; 1989 Apr; 39(4):541-8. PubMed ID: 2784550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of sleep deprivation on cerebral glucose metabolic rate in normal humans assessed with positron emission tomography.
    Wu JC; Gillin JC; Buchsbaum MS; Hershey T; Hazlett E; Sicotte N; Bunney WE
    Sleep; 1991 Apr; 14(2):155-62. PubMed ID: 1866529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cerebral glucose metabolism in dementia (PET-FDG study)].
    Hatazawa J; Itoh M; Matsuzawa T
    Rinsho Hoshasen; 1989 Oct; 34(11):1343-8. PubMed ID: 2601096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The spectrum of prion pathology broadens: fatal familial insomnia].
    Delgado-Reyes S; Feito-Ibarz N; Ruiz-Aláez A; García de la Rocha ML; Martín-Araguz A; Moreno-Martínez JM
    Rev Neurol; 1997 Dec; 25(148):2006-14. PubMed ID: 9528048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Lennox-Gastaut syndrome: metabolic subtypes determined by 2-deoxy-2[18F]fluoro-D-glucose positron emission tomography.
    Chugani HT; Mazziotta JC; Engel J; Phelps ME
    Ann Neurol; 1987 Jan; 21(1):4-13. PubMed ID: 3103528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific structuro-metabolic pattern of thalamic subnuclei in fatal familial insomnia: A PET/MRI imaging study.
    Xie K; Chen Y; Chu M; Cui Y; Chen Z; Zhang J; Liu L; Jing D; Cui C; Liang Z; Ren L; Rosa-Neto P; Ghorayeb I; Zhang Z; Wu L
    Neuroimage Clin; 2022; 34():103026. PubMed ID: 35504222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regional cerebral glucose consumption measured by positron emission tomography in patients with Wilson's disease.
    Kuwert T; Hefter H; Scholz D; Milz M; Weiss P; Arendt G; Herzog H; Loken M; Hennerici M; Feinendegen LE
    Eur J Nucl Med; 1992; 19(2):96-101. PubMed ID: 1563446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reproducibility of cerebral glucose utilization measured by PET and the [18F]-2-fluoro-2-deoxy-d-glucose method in resting, healthy human subjects.
    Maquet P; Dive D; Salmon E; von Frenckel R; Franck G
    Eur J Nucl Med; 1990; 16(4-6):267-73. PubMed ID: 2351175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.